Drugs.com

MARCH 10, 2025

MONDAY, March 10, 2025 -- LED light therapy is touted by social media influencers as a trendy way to treat acne.And it actually appears to work, a new evidence review suggests.Both red and blue LED light therapy are safe and effective in clearing.

Therapies 162

Therapies 162

Drugs.com

MARCH 20, 2025

THURSDAY, March 20, 2025 -- Doctors should prescribe triptans for migraine patients who arent receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from the American College of Physicians.The r.

Therapies 195

Therapies Doctors 195

Elrig

MARCH 25, 2025

Dr Shalini Andersson, Vice President Nucleic Acid TherapeuticsRNA Gene Cell Therapy at Discovery Sciences, AstraZeneca Dr Shalini Andersson, Vice President Nucleic Acid Therapeutics, AstraZeneca, said: Im honoured to be invited to present at Therapeutic Oligonucleotides 2025.

RNA 59

RNA Bioinformatics Science Pharmacokinetics 59

Drugs.com

JANUARY 16, 2025

16, 2025 -- Cutting-edge targeted therapies are pushing back the line between life and death for cancer patients.However, these targeted cancer drugs frequently arent benefitting members of ethnic and racial minorities in the U.S., THURSDAY, Jan.

Drugs 299

Drugs Therapies 299

BioPharma Drive: Drug Pricing

JANUARY 21, 2025

What does 2025 hold for pharma? Find out the top drugs, companies and therapy areas for the year ahead.

Therapies 130

Therapies Drugs 130

Drugs.com

MARCH 31, 2025

MONDAY, March 31, 2025 -- Breast-conserving therapy for breast cancer might not conserve as much as previously thought, a new study suggests.Womens breasts can shrink considerably after theyve undergone radiation therapy and lumpectomy for their e.

Therapies 219

Therapies 219

Broad Institute

JANUARY 14, 2025

By Allessandra DiCorato January 14, 2025 Credit: Maria Nemchuk, Broad Communications Eric Minikel and Sonia Vallabh run a lab with a singular focus: preventing and treating prion disease within their lifetime. Theres still a long way to go to make this a therapy, Minikel said. Online January 14, 2025. Nature Medicine.

Disease 144

Disease DNA Protein Production Treatment 144

Drugs.com

MARCH 5, 2025

WEDNESDAY, March 5, 2025 -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows.The cornea -- the clear outermost layer of the eye -- can become irreversibly damaged if.

Therapies 179

Therapies Treatment 179

Drugs.com

JANUARY 21, 2025

21, 2025 -- Hormone replacement therapy to ease menopause symptoms doesnt increase a womans risk of brain tumors.Researchers found no link between hormone therapy and gliomas, the most common brain tumors in adults, according to res. TUESDAY, Jan.

Therapies 130

Therapies 130

Covalent Modifiers

MARCH 16, 2025

2025 [link] Uncovering a drugs mechanism of action and possible adverse effects are critical components in drug discovery and development. Some of this potentially contributes to the adverse effects experienced by patients undergoing therapy using these drugs. Darragh, Andrew M. Hanna, Justin H. Lipner, Alastair J. King, Nicole B.

FDA 100

FDA Therapies Drugs 100

Broad Institute

FEBRUARY 27, 2025

An ancient RNA-guided system could simplify delivery of gene editing therapies By Corie Lok February 27, 2025 Breadcrumb Home An ancient RNA-guided system could simplify delivery of gene editing therapies The programmable proteins are compact, modular, and can be directed to modify DNA in human cells. Online February 27, 2025.

RNA 66

RNA Therapies DNA Virus 66

Conversations in Drug Development Trends

NOVEMBER 5, 2024

In preparation for World Orphan Drug Congress Europe, we interviewed Nathan Chadwick, Senior Director, Therapeutic Strategy Lead, Rare Disease, and Derek Ansel, MS, LCGC, Vice President, Therapeutic Strategy Lead, Rare Disease, to hear their insights into the current progress in rare disease research and their hopes for 2025.

Disease 52

Disease Clinical Trials Therapies Clinical Research 52

Broad Institute

MARCH 11, 2025

By Count Me In Communications March 11, 2025 Count Me In , a patient-partnered research initiative led by the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute, is launching a new project focused on translocation renal cell carcinoma (tRCC), a rare and aggressive form of kidney cancer.

Research 113

Research Medical Schools Treatment Disease 113

Broad Institute

FEBRUARY 26, 2025

Why brain cancer is often resistant to immunotherapy By Allessandra DiCorato February 26, 2025 Breadcrumb Home Why brain cancer is often resistant to immunotherapy Researchers find four coordinated gene expression programs in immune cells from glioma tumors, including two that could lead to immunotherapy resistance. Online February 26, 2025.

Immune Response 132

Immune Response Treatment RNA Clinical Trials 132

New Drug Approvals

APRIL 2, 2025

1] [2] It was developed by Vertex Pharmaceuticals , [5] and was approved for medical use in the United States in January 2025. [2] 1] [2] It was developed by Vertex Pharmaceuticals , [5] and was approved for medical use in the United States in January 2025. [2] 6 February 2025. 6 February 2025. Retrieved 2 April 2025.

FDA 62

FDA Therapies Trials Treatment 62

SugarCone Biotech

MARCH 2, 2025

The interest from analysts is driven by near-term readouts from the COMPANION-002 Phase 2/3 Study including ORR in March and median PFS later in 2025. In a Phase 2 study of tovecimig + paclitaxel in second and third line BTC, the ORR was 37.5%, the median PFS = 9.4 months and the median OS = 12.5

Therapies 67

Therapies Clinical Trials Trials Clinical Development 67

Drugs.com

MARCH 4, 2025

TUESDAY, March 4, 2025 -- Breast cancer survivors treated with chemotherapy tend to suffer a longer-lasting decline in their physical health, compared to women who receive hormone therapy or other cancer treatments.Chemotherapy patients reported a.

Therapies 147

Therapies 147

Drug Target Review

NOVEMBER 29, 2023

Our primary focus is to design and develop RNA therapies for liver diseases. Our team of chemists then uses this information to develop novel therapies. By doing this, we get a superior understanding of which therapies will and will not work in human biology before a clinical trial.

Therapies 102

Therapies Disease RNA Engineering 102

Drugs.com

JANUARY 26, 2025

26, 2025 -- Could a virtual avatar be the future of mental health care? New research shows that artificial intelligence (AI) and virtual reality (VR) goggles could revolutionize therapy -- helping patients overcome addiction and. SUNDAY, Jan.

Therapies 130

Therapies Research 130

BioPharma Drive: Drug Pricing

AUGUST 14, 2023

The $150 million in fresh funds will help Taysha keep the lights on well into 2025 and support testing of an experimental gene therapy for Rett syndrome.

Therapies 130

Therapies 130

DS in Pharmatics

APRIL 4, 2025

The Center for Biologics Evaluation and Research (CBER) plays a critical role in overseeing the approval of innovative biologic products, including gene therapies, cell-based treatments, and vaccines.

Vaccine 52

Vaccine Therapies Treatment Production 52

Fierce BioTech

FEBRUARY 27, 2025

Successful Scale-Up Of An Upstream Viral Vector Process Using An Adherent Platform swheeler Thu, 02/27/2025 - 11:40 Thu, 04/10/2025 - 11:00 Resource Type Webinar Brian Gardell Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method.

Therapies 52

Therapies Production Disease 52

H1 Blog

DECEMBER 11, 2024

In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Ryan Brown , Regional VP, Trial Landscape Global standards for diversity plans will emerge in 2025. Ariel Katz , CEO & Co-Founder AI will be used to combat rare diseases.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

Fierce BioTech

JANUARY 16, 2025

On Demand Start Date Thu, 03/06/2025 - 13:00 End Date/Time Thu, 03/06/2025 - 12:00 Listing Image CardinalHealth_ListingLogo_250x190.png png Listing Introduction Optimize patient access and overcome barriers with a structured approach to launch planning.

Therapies 52

Therapies Treatment Disease Marketing 52

Alta Sciences

JANUARY 29, 2025

Fast-Track Gene Therapy Discovery With Easy Access to NHPs blussier Wed, 01/29/2025 - 15:57 HTML Speed Up Your Gene Therapy Discovery at Our Sacramento Site Do you need quick, hassle-free access to a large pool of nonhuman primates (NHPs) for your gene therapy discovery work?

Therapies 52

Therapies Production Research 52

Fierce BioTech

MARCH 6, 2025

Join OM1 experts in our upcoming webinar to learn how commercial teams can leverage AI-driven real-world insights and ensure their therapies reach the patients who need them most. On Demand Start Date Tue, 04/08/2025 - 14:00 End Date/Time Tue, 04/08/2025 - 14:00 Listing Image OM1_ListingLogo_250x190.png

Treatment 75

Treatment Therapies Marketing 75

Fierce BioTech

FEBRUARY 14, 2025

Nonviral CRISPR-based knock-in of chimeric antigen receptor transgenes into T cells for cell therapy dwunderlin Fri, 02/14/2025 - 14:52 Thu, 04/03/2025 - 11:00 Resource Type Webinar Krishanu Saha, PhD Max Sellman Join us for an insightful webinar on the latest advancements in cell and gene therapy, focusing on the innovative Cas9-CLIPT technology.

Therapies 52

Therapies DNA Production 52

Fierce BioTech

SEPTEMBER 6, 2024

RWE Impact: When Empowered Patients Drive Pharma Outcomes pesurya Fri, 09/06/2024 - 11:33 Thu, 10/03/2024 - 11:00 Resource Type Webinar Leigh Ann Bruhn Arturo LoAIza-Bonilla MD Nico O'Kuinghttons Cathy Zaremba Promotion Start Mon, 09/09/2024 - 11:45 Promotion End Sun, 03/09/2025 - 11:45 Duration 60 Minutes Discover the transformative power of RWE.

Clinical Trials 98

Clinical Trials Therapies Trials Drugs 98

Alta Sciences

FEBRUARY 19, 2025

Regulatory Guidance for Oligonucleotide Bioanalysis in Drug Development pmjackson Wed, 02/19/2025 - 21:30 The unique physicochemical properties of oligonucleotides require the use of specialized bioanalytical approaches, with key considerations including selectivity and specificity, sensitivity, stability, and matrix effects.

Drug Development 52

Drug Development Clinical Pharmacology Immune Response Drugs 52

Alta Sciences

MARCH 20, 2025

Gene Therapy Studies and Germline Integration Assessment in Nonhuman Primates lperez Thu, 03/20/2025 - 22:44 Publication Poster_Altasciences_SOT_2025Gene_Therapy_Studies_and_Germline_Integration_Assessment_in_NHPs.pdf Tags Preclinical Research Category Poster Weight 1

Therapies 40

Therapies Research 40

Fierce BioTech

MARCH 14, 2025

Advancing the Future of Biomarker-Driven Immunotherapy swheeler Fri, 03/14/2025 - 13:43 Mon, 04/21/2025 - 12:00 Resource Type Webinar Eduard Porta-Pardo Can spatial biomarkers revolutionize patient stratification for immune checkpoint inhibitors?

RNA 59

RNA Clinical Trials Therapies Trials 59

Fierce BioTech

AUGUST 7, 2024

Recent advancements in innovative therapies, particularly antibody-drug conjugates (ADCs) and radioisotope therapies (RIT), have expanded the range of effective cancer treatments. How Does Imaging Support the Development of New Therapeutics?:

Therapies 52

Therapies Clinical Trials Trials Treatment 52

Broad Institute

MARCH 25, 2025

By Leah Eisenstadt March 25, 2025 HEARD organizers, from left to right, Alycia Halladay (Autism Science Foundation), Jenny Mai Phan (George Mason University), and Celia van der Merwe of the NeuroDevelopmental Variability Initiative at the Broad. What are the goals of this effort?

Research 64

Research Science Therapies Production 64

Vial

DECEMBER 8, 2023

With technological innovation and scientific research propelling the development of new therapies, anticipation for the future is high. As we look forward to 2024, several groundbreaking therapies are poised to radically change the landscape of ophthalmology, providing hope and improved treatment options for patients with ocular conditions.

Therapies 52

Therapies Clinical Trials Trials Treatment 52

Broad Institute

NOVEMBER 25, 2024

The L2C Accelerator is focused on vastly shortening the time to develop therapies for rare disease patients by grouping together hundreds (or even thousands) of rare genetic mutations in parallel and identifying many candidate therapeutic targets (i.e. Our vision is to uncover as many nodes as possible in a highly parallel manner.

Clinical Trials 52

Clinical Trials Disease Trials Therapies 52

Alta Sciences

JANUARY 17, 2025

WebinarPreclinical Studies of Gene Therapy Products: Latest Trends lperez Fri, 01/17/2025 - 22:48 Image Website_webinar_Preclinical Studies Gene Therapy_v2.jpg jpg Tags Preclinical Research URL [link] Event End Date Thu, 03/06/2025 - 12:00 Event Start Date Thu, 03/06/2025 - 12:00 Weight 1

Production 40

Production Therapies Research 40

Alta Sciences

JANUARY 31, 2025

Cell and gene Therapy webpage thumbnail 220x180 tchichekian Fri, 01/31/2025 - 20:25 Image Untitled design (17).png png Weight 10

Therapies 40

Therapies 40